GGM Wealth Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$753K Sell
4,848
-50
-1% -$7.82K 0.42% 54
2024
Q4
$708K Sell
4,898
-1,973
-29% -$306K 0.37% 58
2024
Q3
$1.11M Buy
6,871
+3
+0% +$478 0.48% 44
2024
Q2
$1M Buy
6,868
+5
+0.1% +$744 0.46% 48
2024
Q1
$1.05M Sell
6,863
-2,870
-29% -$457K 0.49% 48
2023
Q4
$1.55M Sell
9,733
-344
-3% -$52.7K 0.64% 38
2023
Q3
$1.57M Sell
10,077
-1,410
-12% -$233K 0.68% 35
2023
Q2
$1.82M Buy
11,487
+125
+1% +$20.2K 0.74% 30
2023
Q1
$1.76M Buy
11,362
+13
+0.1% +$2.1K 1.01% 26
2022
Q4
$2.05M Sell
11,349
-26
-0.2% -$4.49K 1.05% 24
2022
Q3
$1.94M Buy
11,375
+1,817
+19% +$307K 1.05% 22
2022
Q2
$1.68M Buy
9,558
+1
+0% +$178 0.94% 25
2022
Q1
$1.75M Buy
9,557
+2,880
+43% +$490K 0.88% 24
2021
Q4
$1.14M Sell
6,677
-73
-1% -$12K 0.91% 30
2021
Q3
$1.11M Buy
6,750
+235
+4% +$40.1K 0.88% 28
2021
Q2
$1.09M Buy
6,515
+2
+0% +$331 0.93% 29
2021
Q1
$1.06M Sell
6,513
-35
-0.5% -$5.66K 0.85% 27
2020
Q4
$1.03M Buy
+6,548
New +$966K 1.02% 25

Other funds holding JNJ

GGM Wealth Advisors's JNJ Position: Q1 2025 in Review

GGM Wealth Advisors reduced its Johnson & Johnson (JNJ) stake by 1% in Q1 2025, selling an estimated $7.82K and leaving 4,848 shares worth $753K. The position accounts for 0.42% of the portfolio, ranked #54.

GGM Wealth Advisors first reported a position in JNJ in Q4 2020 and has held it in 18 quarters since. The position peaked at $2.05M in Q4 2022. 4,148 funds tracked by Wall St. Rank hold JNJ as of Q1 2025.

  • GGM Wealth Advisors held 4,848 shares of Johnson & Johnson worth $753K as of Q1 2025.
  • GGM Wealth Advisors sold 50 Johnson & Johnson shares in Q1 2025, an estimated $7.82K.
  • Johnson & Johnson made up 0.42% of GGM Wealth Advisors's portfolio in Q1 2025, its #54 holding.
  • GGM Wealth Advisors first reported a position in Johnson & Johnson in Q4 2020 and has held it in 18 quarters since.
  • GGM Wealth Advisors's Johnson & Johnson position peaked at $2.05M in Q4 2022.
  • 4,148 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2025.

Based on GGM Wealth Advisors's 13F filing for Q1 2025, filed 1 May 2025.